Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Indian J Biochem Biophys ; 2006 Jun; 43(3): 148-53
Article in English | IMSEAR | ID: sea-28415

ABSTRACT

The effect of denaturants such as urea, sodium dodecylsulphate (SDS), guanidinium hydrochloride (Gu.HCl) on the structure of enzyme 3-hydroxybenzoate-6-hydroxylase was studied using intrinsic fluorescence and far and near-UV-CD spectroscopic techniques. Also, activity profiles of the enzyme, as a function of increasing concentrations of denaturants were studied. The far-UV CD spectrum of the enzyme did not show appreciable alterations in the presence of urea, SDS or Gu.HCl, thereby suggesting that the protein does not undergo gross conformational changes in its alpha-helical secondary structure. The treatment of enzyme with 2 M urea resulted in almost complete loss of catalytic activity, accompanied by the reduction of emission fluorescence of enzyme. Similarly, treatment with 0.01% SDS also caused almost complete loss of activity and quenching of enzyme fluorescence as well as a red shift in the emission peak. In addition, reduction in the intensity of near-UV-CD spectrum, especially at 280 nm was observed. About 70% of the activity was lost by treatment with 20 mM Gu.HCl, accompanied by quenching of intrinsic fluorescence of the enzyme. The change in intrinsic fluorescence of the enzyme in the presence of 5 mM-100 mM Gu.HCI could be correlated to progressive loss of catalytic activity. Thus, intrinsic fluorescence (due to tryptophan residues) could be used as an effective probe to provide an insight into the relation between the activity and subtle conformational changes of the enzyme. The results suggested that denaturants caused very slight conformational changes in the enzyme that perturbed the microenvironment of aromatic amino acid residues such as tryptophan accompanied by reduction or loss of catalytic activity.


Subject(s)
Bacteria/enzymology , Circular Dichroism , Guanidine/pharmacology , Mixed Function Oxygenases/chemistry , Protein Denaturation , Sodium Dodecyl Sulfate/pharmacology , Spectrometry, Fluorescence , Urea/pharmacology
2.
Indian J Biochem Biophys ; 2001 Jun; 38(3): 142-8
Article in English | IMSEAR | ID: sea-28273

ABSTRACT

The amino terminal 1-18 domain of dermaseptin s is an important determinant of its structure as well as the antibacterial activity. A thorough investigation on the structure of the 18-residue peptide (D18) and its binding to model membranes in presence of salt and denaturant guanidinium chloride has been carried out. In presence of salt, there is an increase in the fraction of peptide molecules in helical conformation. In presence of the denaturant, D18 is unordered, but addition of the structure-promoting solvent trifluoroethanol results in a transition to the helical conformation. In presence of denaturant, the peptide is unordered, but binding to lipid vesicles is not abolished. Investigation of model membrane permeabilizing ability of the peptide in solutions containing various proportions of sodium chloride and guanidinium chloride indicates that vesicle permeabilization parallels extent of binding. The peptide thus binds to lipid vesicles in an unfolded state. Since the peptide has propensity to fold into a helical conformation, lipid induced transition to a helical structure occurs, followed by membrane permeabilization as a result of pore formation.


Subject(s)
Amino Acid Sequence , Amphibian Proteins , Anti-Bacterial Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , Circular Dichroism , Guanidine/pharmacology , Molecular Sequence Data , Peptide Biosynthesis , Protein Binding , Protein Conformation , Protein Denaturation , Protein Structure, Secondary , Salts/chemistry , Spectrophotometry , Time Factors , Trifluoroethanol/pharmacology
3.
Braz. j. med. biol. res ; 32(6): 673-82, Jun. 1999. graf
Article in English | LILACS | ID: lil-233699

ABSTRACT

The equilibrium unfolding of bovine trypsinogen was studied by circular dichroism, differential spectra and size exclusion HPLC. The change in free energy of denaturation was delta GH2O = 6.99 + ou - 1.40 kcal/mol for guanidine hydrochloride and delta GH2O = 6.37 + ou - 0.57 kcal/mol for urea. Satisfactory fits of equilibrium unfolding transitions required a three-state model involving an intermediate in addition to the native and unfolded forms. Size exclusion HPLC allowed the detection of an intermediate population of trypsinogen whose Stokes radii varied from 24.1 + ou - 0.4 angstron to 26.0 + ou - 0.3 angstron 1.5 M and 2.5 M guanidine hydrochloride, respectively. During urea denaturation, the range of Stokes radii varied from 23.9 + ou - 0.3 angstron to 25.7 + ou - 0.6 angstron for 4.0 M and 6.0 M urea, respectively. Maximal intrinsic fluorescence was observed at about 3.8 M urea with 8-aniline-1-naphthalene sulfonate (ANS) binding. These experimental data indicate that the unfolding of bovine trypsinogen is not a simple transition and suggest that the equilibrium intermediate population comprises one intermediate that may be characterized as a molten globule. To obtain further insight by studying intermediates representing different stages of unfolding, we hope to gain a better understanding of the complex interrelations between protein conformation and energetics.


Subject(s)
Animals , Cattle , Protein Folding , Trypsinogen/metabolism , Chromatography, High Pressure Liquid , Diuretics, Osmotic/pharmacology , Guanidine/pharmacology , Parasympathomimetics/pharmacology , Protein Denaturation , Urea/pharmacology
4.
Indian J Biochem Biophys ; 1998 Aug; 35(4): 229-35
Article in English | IMSEAR | ID: sea-28159

ABSTRACT

Pyridoxal 5'-phosphate reversibly inhibited thymidylate synthase from Lactobacillus leichmannii. The inhibition was competitive with dUMP (Ki = 1 microM) and non-competitive with 5,10-CH2-THF (Ki = 0.08 microM). Treatment of native or pCMB-treated enzyme with urea (5 M) or guanidine hydrochloride (4 M) resulted in inactivation and dissociation of the homodimer (74 kDa) into monomer (37 kDa).


Subject(s)
Dimerization , Enzyme Inhibitors/pharmacology , Guanidine/pharmacology , Lactobacillus/enzymology , Protein Conformation/drug effects , Pyridoxal Phosphate/pharmacology , Thymidylate Synthase/antagonists & inhibitors , Urea/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL